Benzinga | Feb 11, 2021 12:04PM EST

Oppenheimer Assumes Amdocs at Outperform, Announces Price Target of $84

Oppenheimer analyst Timothy Horan assumes Amdocs (NASDAQ:DOX) with a Outperform rating and announces Price Target of $84.